You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

McKesson
Merck
Express Scripts
Baxter
Colorcon
McKinsey

Last Updated: July 13, 2020

DrugPatentWatch Database Preview

Litigation Details for Apotex Inc. v. Daiichi Sankyo, Inc. (N.D. Ill. 2012)


Email this page to a colleague

» See Plans and Pricing

« Back to Dashboard

Small Molecule Drugs cited in Apotex Inc. v. Daiichi Sankyo, Inc.
The small molecule drugs covered by the patent cited in this case are   Start Trial and   Start Trial .

Details for Apotex Inc. v. Daiichi Sankyo, Inc. (N.D. Ill. 2012)

Date Filed Document No. Description Snippet Link To Document
2016-01-08 135 United States Patents Nos. 6,878,703 (the “703 patent”) and 5,616,599 (the “599 patent”) with the FDA…1) no patent information has been filed with the FDA, (2) the patent has expired, (3) the patent will …infringed the ‘599 patent, and Mylan’s Paragraph IV certifications for that patent were thus converted…ANDA infringed on a patent, and that it should not be considered until that patent expired). Mylan’s ANDAs…Paragraph IV certifications as to the ‘703 patent because that patent, although disclaimed, remains listed External link to document
2014-01-09 49 United States Patents Nos. 6,878,703 (the “‘703 Patent”) and 5,616,599 (the “‘599 Patent”) in connection… no patent information has been filed with the FDA; (II) the patent has expired; (III) the patent will…both Patents ‘703 and ‘599, Daiichi sued Mylan on July 31, 2006 for infringement of the ‘599 patent in …regarding the ‘599 patent, Daiichi statutorily disclaimed every claim of the ‘703 patent pursuant to 35 U.S.C…court found that the ‘599 patent was valid and that Mylan infringed the ‘599 patent. Mylan never brought a External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Baxter
McKesson
McKinsey
Colorcon
Johnson and Johnson
Merck

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.